Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 | MicrobiomeTrials← Back to trialsNCT05630794
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-10-06Est. Completion: 2027-05-01
Enrollment target: 36 participants Locations- University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
- Rhode Island Hospital, Providence, Rhode Island, United States
Other microbiome trials you might be interested in
Colorectal AdenomaColorectal CarcinomaColorectal Conventional Adenoma With Severe DysplasiaColorectal Tubulovillous Adenoma
This randomized phase II clinical trial studies how well MUC1 peptide-poly-ICLC adjuvant vaccine works in treating patie…
Boston, United StatesEst. completion Jan 27, 2017
Colorectal CarcinomaPolypColorectal Adenoma
The goal of this observational study is to evaluate if a blood test for circulating progastrin (hPG80) and transposable …
London, United KingdomEst. completion Aug 31, 2027